InVivoPlus anti-mouse PD-L1 (B7-H1)

Passariello M, D'Alise AM, Esposito A, et al. Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling. Sci Rep. 2019,9(1):13125. doi: 10.1038/s41598-019-49485-3

Grasselly C, Denis M, Bourguignon A, et al. The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent. Front Immunol. 2018,9:2100. doi: 10.3389/fimmu.2018.02100

Stathopoulou C, Gangaplara A, Mallett G, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018,49(2):247-263.e7. doi: 10.1016/j.immuni.2018.05.006

Aloulou M, Carr EJ, Gador M, et al. Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells. Nat Commun. 2016,7:10579. doi: 10.1038/ncomms10579

Kim J, Jeong Ryu S, Oh K, et al. Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help. Nat Commun. 2015,6:7994. doi: 10.1038/ncomms8994

Ngiow SF, Young A, Jacquelot N, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015,75(18):3800-11. doi: 10.1158/0008-5472.CAN-15-1082

Tkachev V, Goodell S, Opipari AW, et al. Programmed death-1 controls T cell survival by regulating oxidative metabolism. J Immunol. 2015,194(12):5789-800. doi: 10.4049/jimmunol.1402180

Zander RA, Obeng-Adjei N, Guthmiller JJ, et al. PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity. Cell Host Microbe. 2015,17(5):628-41. doi: 10.1016/j.chom.2015.03.007

Twyman-Saint Victor C, Rech AJ, Maity A, et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature. 2015,520(7547):373-7. doi: 10.1038/nature14292

Jaworska K, Ratajczak J, Huang L, et al. Both PD-1 ligands protect the kidney from ischemia reperfusion injury. J Immunol. 2015,194(1):325-33. doi: 10.4049/jimmunol.1400497